EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Introduction: The mechanism of EphB4/ephrinB2 in the resistance of chronic myelogenous leukemia to imatinib keeps unknown. Methods: The imatinib resistant chronic myelogenous leukemia cell line-K562-R, was established. EphB4 receptor expression was detected in patients and resistant cells. Cell migr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lin, Xu, Na, Zhang, Jin-fang, Xu, Lu-lu, Zhou, Xuan, Huang, Bin-tao, Li, Yu-ling, Liu, Xiao-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879769/
https://www.ncbi.nlm.nih.gov/pubmed/27226777
http://dx.doi.org/10.7150/ijms.14989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879769/
https://www.ncbi.nlm.nih.gov/pubmed/27226777
http://dx.doi.org/10.7150/ijms.14989

Ejemplares similares